Paruzzo, Luca
 Distribuzione geografica
Continente #
NA - Nord America 183
EU - Europa 132
AS - Asia 85
AF - Africa 2
Totale 402
Nazione #
US - Stati Uniti d'America 181
IT - Italia 89
SG - Singapore 58
IE - Irlanda 12
CN - Cina 11
SE - Svezia 9
ID - Indonesia 7
FI - Finlandia 5
FR - Francia 5
VN - Vietnam 4
KR - Corea 3
CA - Canada 2
CH - Svizzera 2
DE - Germania 2
GB - Regno Unito 2
NG - Nigeria 2
AT - Austria 1
ES - Italia 1
GR - Grecia 1
NO - Norvegia 1
PL - Polonia 1
SA - Arabia Saudita 1
SI - Slovenia 1
TW - Taiwan 1
Totale 402
Città #
Singapore 52
Santa Clara 34
Chandler 19
Fairfield 13
Dublin 12
Turin 11
Ashburn 10
Columbus 8
Jakarta 7
Genoa 6
Milan 6
Nyköping 5
Torino 5
Helsinki 4
Medford 4
Princeton 4
Wilmington 4
Woodbridge 4
Ann Arbor 3
Beijing 3
Cambridge 3
Genova 3
Houston 3
Padova 3
Prineville 3
San Diego 3
Seoul 3
Upper Marlboro 3
Abuja 2
Collegno 2
Formello 2
Hangzhou 2
Hebei 2
Jacksonville 2
Marcon 2
Nichelino 2
Salerno 2
Villanova D'asti 2
Wuhan 2
Bari 1
Cardiff 1
Falkirk 1
Florence 1
Ivry-sur-seine 1
Lappeenranta 1
Lausanne 1
Madrid 1
Mechanicsburg 1
Montréal 1
Nanchang 1
New Castle 1
Nova Gorica 1
Nuremberg 1
Palermo 1
Paris 1
Riverton 1
Rosasco 1
San Mateo 1
Seattle 1
Silea 1
Stavanger 1
Taipei 1
Tivoli 1
Toronto 1
Vienna 1
Zurich 1
Totale 287
Nome #
Melanoma Brain Metastases in the Era of Target Therapies: An Overview 121
Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors 106
High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patients 58
Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma 39
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma 30
Treatment strategies for patients with diffuse large B-cell lymphoma 23
Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective 18
HSCT with Mismatched Unrelated Donors (MMUD): A Comparison of Different Platforms for GvHD Prophylaxis 18
Totale 413
Categoria #
all - tutte 1.842
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.842


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 4 3 7 0 0 6 2 9 5 7 5 14
2021/202280 12 2 6 8 7 5 3 3 2 8 11 13
2022/202384 7 11 4 5 2 13 13 5 6 0 11 7
2023/202464 3 9 3 1 2 6 6 7 3 4 7 13
2024/2025123 0 28 14 16 50 15 0 0 0 0 0 0
Totale 413